HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POOR PROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHEN ADJUSTED WITH COMORBIDITIES

Sevindik O., Guc Z., KAHRAMAN S., Medeni S., Katgi A., Acar C., ...More

13th International Symposium on Myelodysplastic Syndromes (MDS), Washington, Kiribati, 29 April - 02 May 2015, vol.39, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 39
• Doi Number: 10.1016/s0145-2126(15)30248-4
• City: Washington
• Country: Kiribati
• Dokuz Eylül University Affiliated: Yes